Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $46.22 Consensus Price Target from Analysts wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs reissued their outperform rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report released on Tuesday morning, Zacks.com reports. Leerink Partnrs also issued estimates for AnaptysBio’s Q1 2024 earnings at ($1.41) EPS, Q2 2024 earnings at ($1.44) EPS, Q3 2024 earnings at ($1.45) EPS, Q4 2024 earnings at ($1.42) EPS, […]
SG Americas Securities LLC bought a new position in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,875 shares of the biotechnology company’s stock, valued at approximately $126,000. Other large investors also recently modified their […]
AnaptysBio (NASDAQ:ANAB) Trading Up 3.6% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Leerink Partnrs in a research note issued to investors on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for AnaptysBio’s Q1 2024 earnings at ($1.41) EPS, Q2 2024 earnings at ($1.44) EPS, Q3 2024 earnings at ($1.45) EPS, Q4 […]
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) traded up 3.2% on Wednesday . The stock traded as high as $22.37 and last traded at $22.22. 222,281 shares were traded during trading, a decline of 28% from the average session volume of 308,377 shares. The stock had previously closed at $21.53. Wall Street Analyst Weigh In […]
JPMorgan Chase & Co. Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% Following Analyst Downgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.